Resultados de búsqueda - Gansert, Jennifer
- Mostrando 1 - 3 Resultados de 3
-
1
Randomized Phase Ib/II Trial of Rilotumumab or Ganitumab with Panitumumab versus Panitumumab Alone in Patients with Wild-type KRAS Metastatic Colorectal Cancer por Cutsem, Eric Van, Eng, Cathy, Nowara, Elzbieta, Świeboda-Sadlej, Anna, Tebbutt, Niall C., Mitchell, Edith, Davidenko, Irina, Stephenson, Joe, Elez, Elena, Prenen, Hans, Deng, Hongjie, Tang, Rui, McCaffery, Ian, Oliner, Kelly S., Chen, Lisa, Gansert, Jennifer, Loh, Elwyn, Smethurst, Dominic, Tabernero, Josep
Publicado 2014Texto -
2
Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advance... por Chesney, Jason, Puzanov, Igor, Collichio, Frances, Singh, Parminder, Milhem, Mohammed M., Glaspy, John, Hamid, Omid, Ross, Merrick, Friedlander, Philip, Garbe, Claus, Logan, Theodore F., Hauschild, Axel, Lebbé, Celeste, Chen, Lisa, Kim, Jenny J., Gansert, Jennifer, Andtbacka, Robert H.I., Kaufman, Howard L.
Publicado 2018Texto -
3
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy por Ribas, Antoni, Dummer, Reinhard, Puzanov, Igor, VanderWalde, Ari, Andtbacka, Robert H.I., Michielin, Olivier, Olszanski, Anthony J., Malvehy, Josep, Cebon, Jonathan, Fernandez, Eugenio, Kirkwood, John M., Gajewski, Thomas F., Chen, Lisa, Gorski, Kevin S., Anderson, Abraham A., Diede, Scott J., Lassman, Michael E., Gansert, Jennifer, Hodi, F. Stephen, Long, Georgina V.
Publicado 2017Texto